SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-089933
Filing Date
2020-03-30
Accepted
2020-03-30 07:00:36
Documents
3
Period of Report
2020-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d905037d8k.htm 8-K 21435
2 EX-10.1 d905037dex101.htm EX-10.1 26134
3 EX-99.1 d905037dex991.htm EX-99.1 19868
  Complete submission text file 0001193125-20-089933.txt   68773
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 20753946
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences